Heart failure (HF) and type 2 diabetes (T2D) are important multidisciplinary problems both individually and, especially, in combination. The issues of combine effect, as well as modern approaches to the choice of medication remain insufficiently known to practitioners in Russia. The article discusses the epidemiology, pathophysiology and the basic principles of therapy for people with HF and T2D.